Carcinomatous Mastitis: Meaning and Next Steps

Despite the word “mastitis,” this diagnosis is cancer rather than a routine breast infection. Cancer cells obstruct lymph channels in the breast skin, producing inflammation-like changes that can develop quickly. Treatment is planned by a breast cancer team after imaging, biopsy and tests on the cancer cells.

Inflammatory breast cancer commonly presents with rapid swelling, warmth, heaviness, tenderness, red or darker skin, and dimpling that resembles orange peel. The nipple may flatten or turn inward, and lymph nodes under the arm or near the collarbone may enlarge. A distinct lump may be absent. These changes can overlap with infection, injury and other breast conditions, so symptoms alone cannot establish the diagnosis.

A clinician may perform a breast examination and arrange diagnostic imaging such as mammography, ultrasound or magnetic resonance imaging. A biopsy of breast tissue or affected skin is needed to identify cancer cells. Further scans assess whether disease is confined to the breast and nearby nodes or has spread elsewhere, while biomarker tests guide medicine choices.

Treatment usually combines several approaches in a planned sequence. Drug treatment is commonly given first, followed by breast and lymph-node surgery when appropriate, then radiotherapy. Hormone therapy, targeted therapy or immunotherapy may be added according to the tumour's biomarkers and the extent of disease. The oncology team adapts the plan to the person's overall health and treatment response.

Request prompt medical assessment for new breast redness or darkening, rapid enlargement, widespread swelling, orange-peel dimpling, nipple inversion or enlarged nodes under the arm or near the collarbone. Seek reassessment if presumed mastitis does not improve as expected with treatment, especially outside breastfeeding. These warning signs do not confirm cancer, but their rapid or persistent nature means that diagnosis should not be delayed.

Ask which biopsy confirmed the diagnosis, what the imaging shows, and which biomarkers were found. Request an explanation of the treatment order, the goal and expected effects of each treatment, fertility or menopause considerations, and whom to contact for new symptoms between appointments. If the term appears in an older report, ask whether the team is using it to mean inflammatory breast cancer in your specific case.